Last Updated: June 22, 2026

BROMPHENIRAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Brompheniramine, and when can generic versions of Brompheniramine launch?

Brompheniramine is a drug marketed by Alpharma Us Pharms, Kv Pharm, Pharm Assoc, Usl Pharma, Watson Labs, Barr, Ivax Sub Teva Pharms, Newtron Pharms, Nexgen Pharma Inc, Par Pharm, Pioneer Pharms, Upsher Smith Labs, Vitarine, Acella, Alkem Labs Ltd, Bionpharma, Chartwell Molecular, Dr Reddys Labs Sa, Hibrow Hlthcare, Padagis Us, Rhodes Pharms, and Taro. and is included in twenty-six NDAs.

The generic ingredient in BROMPHENIRAMINE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for BROMPHENIRAMINE?
  • What are the global sales for BROMPHENIRAMINE?
  • What is Average Wholesale Price for BROMPHENIRAMINE?
Summary for BROMPHENIRAMINE
US Patents:0
Applicants:22
NDAs:26
DailyMed Link:BROMPHENIRAMINE at DailyMed

US Patents and Regulatory Information for BROMPHENIRAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms BROMPHENIRAMINE MALEATE brompheniramine maleate ELIXIR;ORAL 086936-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alkem Labs Ltd BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 210647-001 Jul 14, 2020 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharm Assoc BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 202940-001 Jul 21, 2014 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Barr BROMPHENIRAMINE MALEATE brompheniramine maleate TABLET;ORAL 084468-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Usl Pharma BROMPHENIRAMINE MALEATE brompheniramine maleate ELIXIR;ORAL 087964-001 Jan 25, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pioneer Pharms BROMPHENIRAMINE MALEATE brompheniramine maleate TABLET;ORAL 088604-001 Jul 13, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Molecular BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 213125-001 Apr 17, 2020 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.